R&D Transforming clinical data management systems for biotechnol... In the dynamic environment of biotechnology trials, the significance of Clinical Data Management systems (CDMs) cannot be overstated.
Digital Data science in healthcare Data science has the potential to transform the healthcare industry by providing insights that can improve patient outcomes.
R&D Ensuring R&D investments deliver maximum potential: Notable ... As the drug development landscape becomes more complex, pharmaceutical and biotech companies understand their business strategies have to evolve.
R&D Data-driven disease research harnessing the genome Ben Hargreaves speaks to the UK Biobank to learn more about their work building a dataset of 500,000 individuals.
R&D Bioanalytical labs need to reimagine data to streamline thei... The fundamental questions in the trial phases of drug development are “Does it work?”, “Is it safe?”, and “What else do we need to know?”
Digital To fight rare diseases, win the data battle first Innovation is the key to evolution. In the pharmaceutical space, brilliant advancements have occurred with drugs with large population pools.
Patients New Boehringer US Head Brian Hilberdink talks GLP-1s, DTx an... At Reuters Pharma USA, editor-in-chief Jonah Comstock caught up with Brian Hilberdink, the new head of US human pharma at Boehringer Ingelheim.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl